Found 34 Enz. Inhib. hit(s) with all data for entry = 11811 TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Affinity DataIC50: 5nMAssay Description:A negative control, a positive control and drug administration groups were set up, with two duplicate wells in each group. For the positive control g...More data for this Ligand-Target Pair
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Affinity DataIC50: 5nMAssay Description:A negative control, a positive control and drug administration groups were set up, with two duplicate wells in each group. For the positive control g...More data for this Ligand-Target Pair
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Affinity DataIC50: 5nMAssay Description:A negative control, a positive control and drug administration groups were set up, with two duplicate wells in each group. For the positive control g...More data for this Ligand-Target Pair
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Affinity DataIC50: 5nMAssay Description:A negative control, a positive control and drug administration groups were set up, with two duplicate wells in each group. For the positive control g...More data for this Ligand-Target Pair
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Affinity DataIC50: 5nMAssay Description:A negative control, a positive control and drug administration groups were set up, with two duplicate wells in each group. For the positive control g...More data for this Ligand-Target Pair
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Affinity DataIC50: 5nMAssay Description:A negative control, a positive control and drug administration groups were set up, with two duplicate wells in each group. For the positive control g...More data for this Ligand-Target Pair
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Affinity DataIC50: 5nMAssay Description:A negative control, a positive control and drug administration groups were set up, with two duplicate wells in each group. For the positive control g...More data for this Ligand-Target Pair
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Affinity DataIC50: 55nMAssay Description:A negative control, a positive control and drug administration groups were set up, with two duplicate wells in each group. For the positive control g...More data for this Ligand-Target Pair
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Affinity DataIC50: 55nMAssay Description:A negative control, a positive control and drug administration groups were set up, with two duplicate wells in each group. For the positive control g...More data for this Ligand-Target Pair
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Affinity DataIC50: 55nMAssay Description:A negative control, a positive control and drug administration groups were set up, with two duplicate wells in each group. For the positive control g...More data for this Ligand-Target Pair
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Affinity DataIC50: 55nMAssay Description:A negative control, a positive control and drug administration groups were set up, with two duplicate wells in each group. For the positive control g...More data for this Ligand-Target Pair
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Affinity DataIC50: 55nMAssay Description:A negative control, a positive control and drug administration groups were set up, with two duplicate wells in each group. For the positive control g...More data for this Ligand-Target Pair
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Affinity DataIC50: 55nMAssay Description:A negative control, a positive control and drug administration groups were set up, with two duplicate wells in each group. For the positive control g...More data for this Ligand-Target Pair
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Affinity DataIC50: 55nMAssay Description:A negative control, a positive control and drug administration groups were set up, with two duplicate wells in each group. For the positive control g...More data for this Ligand-Target Pair
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Affinity DataIC50: 55nMAssay Description:A negative control, a positive control and drug administration groups were set up, with two duplicate wells in each group. For the positive control g...More data for this Ligand-Target Pair
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Affinity DataIC50: 55nMAssay Description:A negative control, a positive control and drug administration groups were set up, with two duplicate wells in each group. For the positive control g...More data for this Ligand-Target Pair
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Affinity DataIC50: 55nMAssay Description:A negative control, a positive control and drug administration groups were set up, with two duplicate wells in each group. For the positive control g...More data for this Ligand-Target Pair
3D Structure (crystal)TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Affinity DataIC50: 55nMAssay Description:A negative control, a positive control and drug administration groups were set up, with two duplicate wells in each group. For the positive control g...More data for this Ligand-Target Pair
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Affinity DataIC50: 55nMAssay Description:A negative control, a positive control and drug administration groups were set up, with two duplicate wells in each group. For the positive control g...More data for this Ligand-Target Pair
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Affinity DataIC50: 55nMAssay Description:A negative control, a positive control and drug administration groups were set up, with two duplicate wells in each group. For the positive control g...More data for this Ligand-Target Pair
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Affinity DataIC50: 550nMAssay Description:A negative control, a positive control and drug administration groups were set up, with two duplicate wells in each group. For the positive control g...More data for this Ligand-Target Pair
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Affinity DataIC50: 550nMAssay Description:A negative control, a positive control and drug administration groups were set up, with two duplicate wells in each group. For the positive control g...More data for this Ligand-Target Pair
TargetProgrammed cell death 1 ligand 1(Homo sapiens (Human))
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Affinity DataKd: 50nMAssay Description:The test compound was dissolved in DMSO to make a stock solution with a final concentration of 10 mM, then diluted to 1× with 1.05× PBS-P+, and then ...More data for this Ligand-Target Pair
TargetProgrammed cell death 1 ligand 1(Homo sapiens (Human))
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Affinity DataKd: 50nMAssay Description:The test compound was dissolved in DMSO to make a stock solution with a final concentration of 10 mM, then diluted to 1× with 1.05× PBS-P+, and then ...More data for this Ligand-Target Pair
TargetProgrammed cell death 1 ligand 1(Homo sapiens (Human))
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Affinity DataKd: 50nMAssay Description:The test compound was dissolved in DMSO to make a stock solution with a final concentration of 10 mM, then diluted to 1× with 1.05× PBS-P+, and then ...More data for this Ligand-Target Pair
TargetProgrammed cell death 1 ligand 1(Homo sapiens (Human))
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Affinity DataKd: 50nMAssay Description:The test compound was dissolved in DMSO to make a stock solution with a final concentration of 10 mM, then diluted to 1× with 1.05× PBS-P+, and then ...More data for this Ligand-Target Pair
TargetProgrammed cell death 1 ligand 1(Homo sapiens (Human))
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Affinity DataKd: 50nMAssay Description:The test compound was dissolved in DMSO to make a stock solution with a final concentration of 10 mM, then diluted to 1× with 1.05× PBS-P+, and then ...More data for this Ligand-Target Pair
TargetProgrammed cell death 1 ligand 1(Homo sapiens (Human))
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Affinity DataKd: 50nMAssay Description:The test compound was dissolved in DMSO to make a stock solution with a final concentration of 10 mM, then diluted to 1× with 1.05× PBS-P+, and then ...More data for this Ligand-Target Pair
TargetProgrammed cell death 1 ligand 1(Homo sapiens (Human))
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Affinity DataKd: 550nMAssay Description:The test compound was dissolved in DMSO to make a stock solution with a final concentration of 10 mM, then diluted to 1× with 1.05× PBS-P+, and then ...More data for this Ligand-Target Pair
TargetProgrammed cell death 1 ligand 1(Homo sapiens (Human))
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Affinity DataKd: 550nMAssay Description:The test compound was dissolved in DMSO to make a stock solution with a final concentration of 10 mM, then diluted to 1× with 1.05× PBS-P+, and then ...More data for this Ligand-Target Pair
TargetProgrammed cell death 1 ligand 1(Homo sapiens (Human))
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Affinity DataKd: 550nMAssay Description:The test compound was dissolved in DMSO to make a stock solution with a final concentration of 10 mM, then diluted to 1× with 1.05× PBS-P+, and then ...More data for this Ligand-Target Pair
TargetProgrammed cell death 1 ligand 1(Homo sapiens (Human))
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Affinity DataKd: 50nMAssay Description:The test compound was dissolved in DMSO to make a stock solution with a final concentration of 10 mM, then diluted to 1× with 1.05× PBS-P+, and then ...More data for this Ligand-Target Pair
TargetProgrammed cell death 1 ligand 1(Homo sapiens (Human))
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Affinity DataKd: 550nMAssay Description:The test compound was dissolved in DMSO to make a stock solution with a final concentration of 10 mM, then diluted to 1× with 1.05× PBS-P+, and then ...More data for this Ligand-Target Pair
TargetProgrammed cell death 1 ligand 1(Homo sapiens (Human))
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Xi'An Xinton Pharmaceutcal Research Co.
US Patent
Affinity DataKd: 50nMAssay Description:The test compound was dissolved in DMSO to make a stock solution with a final concentration of 10 mM, then diluted to 1× with 1.05× PBS-P+, and then ...More data for this Ligand-Target Pair
